ONDANSETRON Side Effects

7015555-0 | Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Hepatotoxicity, Venoocclusive Liver Disease
on Sep 09, 2010 Female patient from , 19 years of age, was diagnosed with pain (What is pain?) and was treated with Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, blood alkaline phosphatase increased, hepatotoxicity, venoocclusive liver disease. Ondansetron dosage: 8mg - 3/day - Iv. During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ALLOPURINOL (300mg - Daily - Oral) (View Allopurinol Review and Allopurinol Label ), CASPOFUNGIN ACETATE (70mg - Daily - Iv) (View Caspofungin Acetate Review and Caspofungin Acetate Label ), CHLORPHENIRAMINE MALEATE (10mg - 4 Times Daily - Iv) (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), ETOPOPHOS PRESERVATIVE FREE (4650mg) (View Etopophos Preservative Free Review and Etopophos Preservative Free Label ), KETALAR (6ml - 1 Hours - Iv) (View Ketalar Review and Ketalar Label ), MORPHINE (Iv) (View Morphine Review and Morphine Label ).

7010312-3 | Dilatation Intrahepatic Duct Acquired, Hepatotoxicity, Venoocclusive Liver Disease
Patient was taking Ondansetron (View Usage). Patient had the following side effects: dilatation intrahepatic duct acquired, hepatotoxicity, venoocclusive liver disease on Sep 17, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 19 years of age, . Ondansetron dosage: 24mg Per Day. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), ALLOPURINOL (300mg Per Day) (View Allopurinol Review and Allopurinol Label ), MORPHINE (View Morphine Review and Morphine Label ), CHLORPHENIRAMINE MALEATE (40mg Per Day) (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), NORETHIDRONE (15mg Per Day) (View Norethidrone Review and Norethidrone Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), CASPOFUNGIN ACETATE (70mg Per Day) (View Caspofungin Acetate Review and Caspofungin Acetate Label ).

7009373-7 | Hepatotoxicity, Venoocclusive Liver Disease
Adverse event was reported on Sep 07, 2010 by a Female patient taking Ondansetron (View Usage) (Dosage: 6mg-daily-) was diagnosed with pain (What is pain?) and. Location: , 19 years of age, After Ondansetron was administered, patient had the following side effects: hepatotoxicity, venoocclusive liver disease. During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), ALLOPURINOL (300mg-daily-) (View Allopurinol Review and Allopurinol Label ), CASPOFUNGIN ACETATE (70mg-daily-) (View Caspofungin Acetate Review and Caspofungin Acetate Label ), CHLORPHENIRAMINE MALEATE (10mg - 4 Times Daily-) (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), ETOPOPHOS PRESERVATIVE FREE (4650mg) (View Etopophos Preservative Free Review and Etopophos Preservative Free Label ), KETALAR (View Ketalar Review and Ketalar Label ), MORPHINE (Iv) (View Morphine Review and Morphine Label ).

6992533-9 | Febrile Neutropenia
on Aug 31, 2010 Female patient from NORWAY , child 9 years of age, was treated with Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia. Ondansetron dosage: . During the same period patient was treated with VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), APREPITANT (View Aprepitant Review and Aprepitant Label ), COSMEGEN (View Cosmegen Review and Cosmegen Label ).


6982645-8 | Flushing, Hyperhidrosis, Tremor
on Aug 25, 2010 Male patient from UNITED STATES , 67 years of age, was diagnosed with nausea (What is nausea?) and was treated with Ondansetron (View Usage). Patient had the following side effects: flushing, hyperhidrosis, tremor. Ondansetron dosage: 4 Mg, Q6h; Iv.

6976861-9 | Dilatation Intrahepatic Duct Acquired, Hepatotoxicity, Liver Function Test Abnormal, Venoocclusive Liver Disease
Patient was taking Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: dilatation intrahepatic duct acquired, hepatotoxicity, liver function test abnormal, venoocclusive liver disease on Sep 09, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 19 years of age, . Ondansetron dosage: 24mg Per Day. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), ALLOPURINOL (300mg Per Day) (View Allopurinol Review and Allopurinol Label ), MORPHINE (View Morphine Review and Morphine Label ), CHLORPHENAMINE (40mg Per Day) (View Chlorphenamine Review and Chlorphenamine Label ), NORETHISTERONE (15mg Per Day) (View Norethisterone Review and Norethisterone Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), CASPOFUNGIN (70mg Per Day) (View Caspofungin Review and Caspofungin Label ).

6973936-5 | Procedural Nausea, Procedural Vomiting, Respiratory Acidosis, Ventricular Extrasystoles, Ventricular Tachycardia
Adverse event was reported on Sep 03, 2010 by a Female patient taking Ondansetron (View Usage) (Dosage: ) was diagnosed with prophylaxis of nausea and vomiting and. Location: , child 11 years of age, weighting 77.16 lb, Patient experienced the following unwanted or unexpected effects: procedural nausea, procedural vomiting, respiratory acidosis, ventricular extrasystoles, ventricular tachycardia. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), REMIFENTANIL (View Remifentanil Review and Remifentanil Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), DIMENHYDRINATE (View Dimenhydrinate Review and Dimenhydrinate Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ). Patient was hospitalized.

6973882-7 | Febrile Neutropenia
on Aug 31, 2010 Female patient from NORWAY , child 9 years of age, was treated with Ondansetron (View Usage). Patient had the following side effects: febrile neutropenia. Ondansetron dosage: . During the same period patient was treated with APREPITANT (View Aprepitant Review and Aprepitant Label ), COSMEGEN (View Cosmegen Review and Cosmegen Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ).

6973846-3 | Dilatation Intrahepatic Duct Acquired, Hepatotoxicity, Liver Function Test Abnormal, Venoocclusive Liver Disease
on Sep 08, 2010 Female patient from UNITED KINGDOM , 19 years of age, was treated with Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: dilatation intrahepatic duct acquired, hepatotoxicity, liver function test abnormal, venoocclusive liver disease. Ondansetron dosage: 6mg Per Day. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), ALLOPURINOL (300mg Per Day) (View Allopurinol Review and Allopurinol Label ), MORPHINE (View Morphine Review and Morphine Label ), CHLORPHENAMINE (40mg Per Day) (View Chlorphenamine Review and Chlorphenamine Label ), NORETHISTERONE (15mg Per Day) (View Norethisterone Review and Norethisterone Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), CASPOFUNGIN (70mg Per Day) (View Caspofungin Review and Caspofungin Label ).

6971978-7 | Ventricular Tachycardia
Patient was taking Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: ventricular tachycardia on Aug 24, 2010 from CANADA Additional patient health information: Female patient , child 11 years of age, was diagnosed with procedural nausea, induction of anaesthesia, maintenance of anaesthesia and. Ondansetron dosage: . During the same period patient was treated with SEVOFLURANE (In Oxygen And Nitrous Oxide) (View Sevoflurane Review and Sevoflurane Label ), REMIFENTANIL (View Remifentanil Review and Remifentanil Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), DIMENHYDRINATE (View Dimenhydrinate Review and Dimenhydrinate Label ).

6971200-1 | Ventricular Tachycardia
Adverse event was reported on Aug 24, 2010 by a Female patient taking Ondansetron (View Usage) (Dosage: ) was diagnosed with procedural nausea, induction of anaesthesia, maintenance of anaesthesia and. Location: CANADA , child 11 years of age, Patient had the following side effects: ventricular tachycardia. During the same period patient was treated with SEVOFLURANE (In Oxygen And Nitrous Oxide) (View Sevoflurane Review and Sevoflurane Label ), REMIFENTANIL (View Remifentanil Review and Remifentanil Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), DIMENHYDRINATE (View Dimenhydrinate Review and Dimenhydrinate Label ).

6969055-4 | Ventricular Tachycardia
on Aug 24, 2010 Female patient from CANADA , child 11 years of age, was diagnosed with procedural nausea, induction of anaesthesia, maintenance of anaesthesia and was treated with Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: ventricular tachycardia. Ondansetron dosage: . During the same period patient was treated with SEVOFLURANE (In Oxygen And Nitrous Oxide) (View Sevoflurane Review and Sevoflurane Label ), REMIFENTANIL (View Remifentanil Review and Remifentanil Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), DIMENHYDRINATE (View Dimenhydrinate Review and Dimenhydrinate Label ).

6963897-7 | Electrocardiogram Qt Prolonged, Ventricular Extrasystoles, Ventricular Tachycardia
on Aug 05, 2010 Female patient from UNITED KINGDOM , child 11 years of age, was treated with Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged, ventricular extrasystoles, ventricular tachycardia. Ondansetron dosage: 0.1 Mg.kg (-1) Once Iv. During the same period patient was treated with DIMENHYDRINATE (0.4 Mg-kg (-1 Onece Iv) (View Dimenhydrinate Review and Dimenhydrinate Label ). Patient was hospitalized.

6946765-6 | Blood Potassium Increased, Bronchopneumonia, Cardiac Arrest, Echovirus Test Positive, Hyperthermia Malignant, Infective Thrombosis, Liver Disorder, Lymphadenopathy
Patient was taking Ondansetron (View Usage). Patient had the following side effects: blood potassium increased, bronchopneumonia, cardiac arrest (What is cardiac arrest?), echovirus test positive, hyperthermia malignant, infective thrombosis, liver disorder, lymphadenopathy on Aug 12, 2010 from UNITED KINGDOM Additional patient health information: Male patient , child 6 years of age, was diagnosed with nausea (What is nausea?) and. Ondansetron dosage: 2 Mg Sublingual. Patient was hospitalized.

6945668-0 | Electrocardiogram Qt Prolonged, Ventricular Extrasystoles, Ventricular Tachycardia
Adverse event was reported on Aug 19, 2010 by a Female patient taking Ondansetron (View Usage) (Dosage: 0.1 Mg/kg, Unk) was diagnosed with prophylaxis of nausea and vomiting, maintenance of anaesthesia and. Location: CANADA , child 11 years of age, weighting 77.16 lb, After Ondansetron was administered, patient had the following side effects: electrocardiogram qt prolonged, ventricular extrasystoles, ventricular tachycardia. During the same period patient was treated with SEVOFLURANE (4 % In Nitrous Oxide And Oxygen) (View Sevoflurane Review and Sevoflurane Label ), REMIFENTANIL (1.4 Ug/kg (50 Ug)) (View Remifentanil Review and Remifentanil Label ), ROCURONIUM BROMIDE (0.3 Mg/kg (10 Mg)) (View Rocuronium Bromide Review and Rocuronium Bromide Label ), DEXAMETHASONE (0.1 Mg/kg (3.5 Mg)) (View Dexamethasone Review and Dexamethasone Label ), DIMENHYDRINATE (0.4 Mg/kg, Unk) (View Dimenhydrinate Review and Dimenhydrinate Label ).

6945564-9 | Flushing, Tremor
on Aug 07, 2010 Male patient from UNITED STATES , 67 years of age, was diagnosed with nausea (What is nausea?) and was treated with Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: flushing, tremor. Ondansetron dosage: 4 Mg; Q6h; Iv.

6937715-7 | Confusional State, Depressed Level Of Consciousness, Lethargy, Vomiting
on Aug 20, 2010 Female patient from UNITED STATES , child 4 years of age, weighting 35.27 lb, was diagnosed with antiemetic supportive care and was treated with Ondansetron (View Usage). Patient had the following side effects: confusional state, depressed level of consciousness, lethargy, vomiting. Ondansetron dosage: 4 Mg Once Iv. During the same period patient was treated with SODIUM CHLORIDE 0.9% 100 ML BAG HOSPIRA (Ns 100 Ml Once Iv) (View Sodium Chloride 0.9% 100 Ml Bag Hospira Review and Sodium Chloride 0.9% 100 Ml Bag Hospira Label ). Patient was hospitalized.

6936957-4 | Electrocardiogram Qt Prolonged, Ventricular Extrasystoles, Ventricular Tachycardia
Patient was taking Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: electrocardiogram qt prolonged, ventricular extrasystoles, ventricular tachycardia on Aug 05, 2010 from UNITED KINGDOM Additional patient health information: Female patient , child 11 years of age, . Ondansetron dosage: 0.1 Rng.kg(-1) Once Iv. During the same period patient was treated with DIMENHYDRINATE (0.4 Mg. Kg (-1 Once Iv) (View Dimenhydrinate Review and Dimenhydrinate Label ). Patient was hospitalized.

6936731-9 | Atrioventricular Block Complete
Adverse event was reported on Aug 05, 2010 by a Female patient taking Ondansetron (View Usage) (Dosage: 4 Mg Intravenous) was diagnosed with vomiting and. Location: UNITED KINGDOM , 59 years of age, weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: atrioventricular block complete. During the same period patient was treated with DOMPERIDONE (20 Mg Oral) (View Domperidone Review and Domperidone Label ).

6935966-9 | Atrioventricular Block Complete
on Aug 02, 2010 Female patient from UNITED KINGDOM , 57 years of age, was diagnosed with prophylaxis and was treated with Ondansetron (View Usage). Patient had the following side effects: atrioventricular block complete. Ondansetron dosage: 4 Mg; Intravenous (not Otherwise Specified). During the same period patient was treated with DOMPERIDONE (View Domperidone Review and Domperidone Label ).

6935939-6 | Migraine
on Aug 03, 2010 Female patient from UNITED KINGDOM , 26 years of age, was diagnosed with prophylaxis and was treated with Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: migraine (What is migraine?). Ondansetron dosage: 4 Mg, (three Days Later). During the same period patient was treated with FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6930268-9 | Atrioventricular Block Complete
Patient was taking Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block complete on Aug 05, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 59 years of age, weighting 165.3 lb, was diagnosed with prophylaxis and. Ondansetron dosage: 4 Mg, Intravenous. During the same period patient was treated with DOMPERIDONE (DOMPERIDONE) (20 Mg, Oral) (View Domperidone (domperidone) Review and Domperidone (domperidone) Label ).

6929185-X | Atrioventricular Block Complete
Adverse event was reported on Aug 05, 2010 by a Female patient taking Ondansetron (View Usage) (Dosage: 4 Mg Milligram(s), Intravenous) was diagnosed with vomiting and. Location: UNITED KINGDOM , 59 years of age, weighting 75.00 lb, Patient had the following side effects: atrioventricular block complete. During the same period patient was treated with DOMPERIDONE (20 Mg Milligram(s0, Oral) (View Domperidone Review and Domperidone Label ).

6923688-X | Arrhythmia, Electrocardiogram Qt Prolonged, Procedural Nausea, Procedural Vomiting, Respiratory Acidosis, Sinus Rhythm, Ventricular Extrasystoles, Ventricular Tachycardia
on Aug 06, 2010 Female patient from CANADA , child 11 years of age, weighting 77.16 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), electrocardiogram qt prolonged, procedural nausea, procedural vomiting, respiratory acidosis, sinus rhythm, ventricular extrasystoles, ventricular tachycardia. Ondansetron dosage: .1mgk Single Dose. During the same period patient was treated with DIMENHYDRINATE (.4mgk Single Dose) (View Dimenhydrinate Review and Dimenhydrinate Label ), DEXAMETHASONE (3.5mg Single Dose) (View Dexamethasone Review and Dexamethasone Label ), LIDOCAINE (1mgk Single Dose) (View Lidocaine Review and Lidocaine Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), FENTANYL (.5ugk Single Dose) (View Fentanyl Review and Fentanyl Label ), REMIFENTANIL (50ug Single Dose) (View Remifentanil Review and Remifentanil Label ), ROCURONIUM BROMIDE (10mg Single Dose) (View Rocuronium Bromide Review and Rocuronium Bromide Label ).

6921294-4 | Atrioventricular Block Complete
on Aug 05, 2010 Female patient from UNITED KINGDOM , 59 years of age, weighting 165.3 lb, was diagnosed with vomiting and was treated with Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block complete. Ondansetron dosage: . During the same period patient was treated with DOMPERIDONE (View Domperidone Review and Domperidone Label ).

6916774-1 | Atrioventricular Block Complete
Patient was taking Ondansetron (View Usage). Patient had the following side effects: atrioventricular block complete on Jul 22, 2010 from Additional patient health information: Female patient , 59 years of age, weighting 165.3 lb, was diagnosed with prophylaxis and. Ondansetron dosage: 4mg, Intravenous. During the same period patient was treated with DOMPERIDONE (20 Mg, Oral) (View Domperidone Review and Domperidone Label ).

6907361-X | Atrioventricular Block Complete
Adverse event was reported on Jul 22, 2010 by a Female patient taking Ondansetron (View Usage) (Dosage: 4 Mg, Intravenous) was diagnosed with prophylaxis and. Location: UNITED KINGDOM , 59 years of age, weighting 165.3 lb, After Ondansetron was administered, patient had the following side effects: atrioventricular block complete. During the same period patient was treated with DOMPERIDONE (DOMPERIDONE) (20 Mg, Oral) (View Domperidone (domperidone) Review and Domperidone (domperidone) Label ).

6896320-1 | Condition Aggravated, Flushing, Tremor
on Jul 21, 2010 Male patient from UNITED STATES , 67 years of age, was diagnosed with nausea (What is nausea?) and was treated with Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, flushing, tremor. Ondansetron dosage: 4 Mg Milligram(s), Intravenous ; 4 Mg Milligram(s), Intravenous.

6878689-7 | Atrioventricular Block Complete
on Jul 22, 2010 Female patient from UNITED KINGDOM , 59 years of age, weighting 165.3 lb, was diagnosed with prophylaxis and was treated with Ondansetron (View Usage). Patient had the following side effects: atrioventricular block complete. Ondansetron dosage: . During the same period patient was treated with DOMPERIDONE (View Domperidone Review and Domperidone Label ).

6867723-6 | Withdrawal Syndrome
Patient was taking Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: withdrawal syndrome on Jul 14, 2010 from UNITED STATES Additional patient health information: Male patient , 67 years of age, was diagnosed with nausea (What is nausea?) and. Ondansetron dosage: .

6822820-6 | Dyspnoea, Flushing, Urticaria, Wheezing
Adverse event was reported on Jul 06, 2010 by a Female patient taking Ondansetron (View Usage) (Dosage: 4 Mg 1x Po) was diagnosed with nausea (What is nausea?) and. Location: UNITED STATES , 28 years of age, Patient experienced the following unwanted or unexpected effects: dyspnoea, flushing, urticaria, wheezing. During the same period patient was treated with TRAZODONE (View Trazodone Review and Trazodone Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), CARISOPRODOL (View Carisoprodol Review and Carisoprodol Label ).

6816104-X | Angioedema
on Jul 02, 2010 Male patient from UNITED STATES , 63 years of age, weighting 160.1 lb, was diagnosed with nausea (What is nausea?) and was treated with Ondansetron (View Usage). Patient had the following side effects: angioedema. Ondansetron dosage: 8 Mg Once Po. Patient was hospitalized.

6811970-6 | Acute Myocardial Infarction, Crying, Emotional Disorder, Hypomagnesaemia, Stress, Stress Cardiomyopathy, Torsade De Pointes
on Jun 08, 2010 Female patient from UNITED KINGDOM , 67 years of age, was diagnosed with nausea (What is nausea?), depression (What is depression?) and was treated with Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: acute myocardial infarction, crying, emotional disorder, hypomagnesaemia, stress (What is stress?), stress cardiomyopathy, torsade de pointes. Ondansetron dosage: 4 Mg, Twice Daily. During the same period patient was treated with FLUOXETINE (60 Mg) (View Fluoxetine Review and Fluoxetine Label ). Patient was hospitalized.

6786507-0 | Bradyphrenia, Pyrexia, Somnolence, Staphylococcal Infection, Urinary Tract Infection
Patient was taking Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: bradyphrenia, pyrexia, somnolence, staphylococcal infection (What is staphylococcal infection?), urinary tract infection (What is urinary tract infection?) on May 04, 2010 from UNITED STATES Additional patient health information: Female patient , 47 years of age, was diagnosed with vomiting, pain (What is pain?), ovarian cancer and. Ondansetron dosage: . During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ), DOXORUBICIN HCL (61.76mg Cyclic) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), PHENTANYL (View Phentanyl Review and Phentanyl Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), FLUOXETINE HYDROCHLORIDE (View Fluoxetine Hydrochloride Review and Fluoxetine Hydrochloride Label ), TRAZODONE HYDROCHLORIDE (View Trazodone Hydrochloride Review and Trazodone Hydrochloride Label ). Patient was hospitalized.

6784644-8 | Bradyphrenia, Somnolence
Adverse event was reported on May 04, 2010 by a Female patient taking Ondansetron (View Usage) (Dosage: ) was diagnosed with vomiting, ovarian cancer, pain (What is pain?) and. Location: UNITED STATES , 47 years of age, Patient had the following side effects: bradyphrenia, somnolence. During the same period patient was treated with DOXORUBICIN HCL (61.76mg Cyclic) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), PHENTANYL (View Phentanyl Review and Phentanyl Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), FLUOXETINE HYDROCHLORIDE (View Fluoxetine Hydrochloride Review and Fluoxetine Hydrochloride Label ), MORPHINE (View Morphine Review and Morphine Label ), TRAZODONE HYDROCHLORIDE (View Trazodone Hydrochloride Review and Trazodone Hydrochloride Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ). Patient was hospitalized.

6765514-8 | Diplopia, Flushing, Intraventricular Haemorrhage, Withdrawal Syndrome
on May 25, 2010 Male patient from UNITED STATES , 67 years of age, was diagnosed with nausea (What is nausea?) and was treated with Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: diplopia, flushing, intraventricular haemorrhage, withdrawal syndrome. Ondansetron dosage: 4mg - Q6 Hr - Iv.

6763857-5 | Hypomagnesaemia, Long Qt Syndrome, Stress Cardiomyopathy, Torsade De Pointes
on Jun 07, 2010 Female patient from , 67 years of age, was diagnosed with nausea (What is nausea?), depression (What is depression?) and was treated with Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: hypomagnesaemia, long qt syndrome, stress cardiomyopathy, torsade de pointes. Ondansetron dosage: 8 Mg. During the same period patient was treated with FLUOXETINE (60 Mg) (View Fluoxetine Review and Fluoxetine Label ).

6759053-8 | Bronchopneumonia, Cardiac Arrest, Enterovirus Test Positive, Hepatic Infection Bacterial, Hyperthermia, Lymphadenopathy, Muscle Rigidity, Thrombosis
Patient was taking Ondansetron (View Usage). Patient had the following side effects: bronchopneumonia, cardiac arrest (What is cardiac arrest?), enterovirus test positive, hepatic infection bacterial, hyperthermia, lymphadenopathy, muscle rigidity, thrombosis on May 17, 2010 from UNITED STATES Additional patient health information: Male patient , child 5 years of age, was diagnosed with abdominal pain (What is abdominal pain?), vomiting and. Ondansetron dosage: 2 Mg, 1 In 1 Total, Sublingual/once. Patient was hospitalized.

6750966-X | Blood Potassium Increased, Bronchopneumonia, Cardiac Arrest, Enterovirus Test Positive, Hepatic Infection Bacterial, Hyperthermia, Lymphadenopathy, Muscle Rigidity
Adverse event was reported on May 14, 2010 by a Male patient taking Ondansetron (View Usage) (Dosage: 2mg - X1 - Sublingually/ 1 Dose) was diagnosed with vomiting and. Location: , child 5 years of age, After Ondansetron was administered, patient had the following side effects: blood potassium increased, bronchopneumonia, cardiac arrest (What is cardiac arrest?), enterovirus test positive, hepatic infection bacterial, hyperthermia, lymphadenopathy, muscle rigidity.

6744349-6 | Agitation, Anxiety, Confusional State, Delirium
on May 26, 2010 Male patient from UNITED STATES , 90 years of age, weighting 181.0 lb, was diagnosed with nausea (What is nausea?) and was treated with Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, anxiety (What is anxiety?), confusional state, delirium. Ondansetron dosage: 4 Mg Prn Iv. Patient was hospitalized.

6735959-0 | Bronchopneumonia, Cardiac Arrest, Enterovirus Infection, Hyperthermia Malignant, Lymphadenopathy, Muscle Rigidity, Thrombosis, Ventricular Tachycardia
on May 21, 2010 Male patient from SPAIN , child 5 years of age, was diagnosed with vomiting and was treated with Ondansetron (View Usage). Patient had the following side effects: bronchopneumonia, cardiac arrest (What is cardiac arrest?), enterovirus infection, hyperthermia malignant, lymphadenopathy, muscle rigidity, thrombosis, ventricular tachycardia. Ondansetron dosage: . Patient was hospitalized.

6726398-7 | Bradyphrenia, Overdose, Pyrexia, Somnolence
Patient was taking Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: bradyphrenia, overdose, pyrexia, somnolence on May 04, 2010 from UNITED STATES Additional patient health information: Female patient , 47 years of age, was diagnosed with vomiting, ovarian cancer, pain (What is pain?), depression (What is depression?) and. Ondansetron dosage: . During the same period patient was treated with DOXORUBICIN HCL (61.76mg Cyclic) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), PHENTANYL (View Phentanyl Review and Phentanyl Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), FLUOXETINE HYDROCHLORIDE (View Fluoxetine Hydrochloride Review and Fluoxetine Hydrochloride Label ), MORPHINE (View Morphine Review and Morphine Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ). Patient was hospitalized.

6723342-3 | Acute Myocardial Infarction, Blood Magnesium Decreased, Blood Potassium Decreased, Electrocardiogram T Wave Inversion, Stress Cardiomyopathy, Torsade De Pointes
Adverse event was reported on Apr 29, 2010 by a Female patient taking Ondansetron (View Usage) (Dosage: 4 Mg Bd) was diagnosed with nausea (What is nausea?), depression (What is depression?) and. Location: UNITED KINGDOM , 67 years of age, Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, blood magnesium decreased, blood potassium decreased, electrocardiogram t wave inversion, stress cardiomyopathy, torsade de pointes. During the same period patient was treated with FLUOXETINE (60 Mg) (View Fluoxetine Review and Fluoxetine Label ).

6702993-6 | Abnormal Behaviour, Extrapyramidal Disorder, Tardive Dyskinesia
on Apr 29, 2010 Female patient from UNITED STATES , weighting 93.26 lb, was diagnosed with nausea (What is nausea?) and was treated with Ondansetron (View Usage). Patient had the following side effects: abnormal behaviour, extrapyramidal disorder, tardive dyskinesia. Ondansetron dosage: 4 Mg Once Iv.

6696491-6 | Abdominal Pain Upper, Nausea
on Oct 07, 2009 Female patient from UNITED STATES , child 12 years of age, was treated with Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: abdominal pain upper, nausea (What is nausea?). Ondansetron dosage: 4mg Variable Dose. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), SINGULAIR (View Singulair Review and Singulair Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ).

6696488-6 | Product Quality Issue
Patient was taking Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: product quality issue on Jul 08, 2009 from UNITED STATES Additional patient health information: Female patient , 54 years of age, was diagnosed with nausea (What is nausea?), pain (What is pain?), anxiety (What is anxiety?) and. Ondansetron dosage: . During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

6696487-4 | Product Quality Issue
Adverse event was reported on Jul 08, 2009 by a Female patient taking Ondansetron (View Usage) (Dosage: 4mg Twice Per Day) was diagnosed with nausea (What is nausea?) and. Location: UNITED STATES , 59 years of age, weighting 135.4 lb, Patient had the following side effects: product quality issue.

6696486-2 | Product Quality Issue
on May 29, 2009 Female patient from UNITED STATES , 27 years of age, weighting 145.3 lb, was diagnosed with nausea (What is nausea?) and was treated with Ondansetron (View Usage). After Ondansetron was administered, patient had the following side effects: product quality issue. Ondansetron dosage: 4mg As Required.

6696466-7 | Abnormal Sensation In Eye, Accidental Exposure, Eye Irrigation
on Sep 22, 2009 Female patient from UNITED STATES , 32 years of age, was treated with Ondansetron (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal sensation in eye, accidental exposure, eye irrigation. Ondansetron dosage: .

6695897-9 | Asthenia, Blood Creatinine Increased, Nausea
Patient was taking Ondansetron (View Usage). Patient had the following side effects: asthenia, blood creatinine increased, nausea (What is nausea?) on Aug 04, 2009 from UNITED STATES Additional patient health information: Female patient , 64 years of age, was diagnosed with prophylaxis of nausea and vomiting, breast cancer (What is breast cancer?) and. Ondansetron dosage: 4mg Three Times Per Day. During the same period patient was treated with TYKERB (4tab Per Day) (View Tykerb Review and Tykerb Label ), HERCEPTIN (View Herceptin Review and Herceptin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).